Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Kimball AB, Delevry D, Yang M, Chuang CC, Wang Z, Bégo-Le-Bagousse G, Martins B, Wu E, Shumel B, Wang J, Sierka D, Chao J, Strober B. Kimball AB, et al. Among authors: sierka d. Dermatol Ther (Heidelb). 2023 Sep;13(9):2107-2120. doi: 10.1007/s13555-023-00965-5. Epub 2023 Aug 8. Dermatol Ther (Heidelb). 2023. PMID: 37552431 Free PMC article.
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective.
de Bruin-Weller M, Merola JF, Hong CH, Baldrich ES, Ettler K, Sierka D, Delevry D, Chen Z, Rossi AB. de Bruin-Weller M, et al. Among authors: sierka d. Dermatol Ther (Heidelb). 2021 Dec;11(6):2123-2131. doi: 10.1007/s13555-021-00621-w. Epub 2021 Nov 12. Dermatol Ther (Heidelb). 2021. PMID: 34767181 Free PMC article.
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.
Eichenfield LF, Armstrong A, Guttman-Yassky E, Lio PA, Chen CC, Hines DM, McGuiness CB, Ganguli S, Delevry D, Sierka D, Mallya UG. Eichenfield LF, et al. Among authors: sierka d. Dermatol Ther (Heidelb). 2022 Jun;12(6):1337-1350. doi: 10.1007/s13555-022-00731-z. Epub 2022 May 11. Dermatol Ther (Heidelb). 2022. PMID: 35543920 Free PMC article.
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
Simpson EL, Paller AS, Siegfried EC, Thaçi D, Wollenberg A, Cork MJ, Marcoux D, Huang R, Chen Z, Rossi AB, Shumel B, Sierka D, Bansal A. Simpson EL, et al. Among authors: sierka d. Dermatol Ther (Heidelb). 2021 Oct;11(5):1643-1656. doi: 10.1007/s13555-021-00568-y. Epub 2021 Aug 24. Dermatol Ther (Heidelb). 2021. PMID: 34427891 Free PMC article.
Tolerability of Topical Treatments for Atopic Dermatitis.
Draelos ZD, Feldman SR, Berman B, Olivadoti M, Sierka D, Tallman AM, Zielinski MA, Ports WC, Baldwin S. Draelos ZD, et al. Among authors: sierka d. Dermatol Ther (Heidelb). 2019 Mar;9(1):71-102. doi: 10.1007/s13555-019-0280-7. Epub 2019 Jan 24. Dermatol Ther (Heidelb). 2019. PMID: 30680551 Free PMC article. Review.
Real-world persistence with dupilumab among adults with atopic dermatitis.
Silverberg JI, Guttman-Yassky E, Gadkari A, Kuznik A, Mallya UG, Mastey V, Zhang H, Chen Z, Chen C, Korotzer A, Sierka D, Fenton MC, Kaur M, Jalbert JJ. Silverberg JI, et al. Among authors: sierka d. Ann Allergy Asthma Immunol. 2021 Jan;126(1):40-45. doi: 10.1016/j.anai.2020.07.026. Epub 2020 Jul 31. Ann Allergy Asthma Immunol. 2021. PMID: 32739313 Free article.
Topical Agents for the Treatment of Atopic Dermatitis.
Eichenfield LF, Luger T, Papp K, Silverberg JI, Sierka D, Zang C, Tallman AM, Zielinski MA, Ports WC. Eichenfield LF, et al. Among authors: sierka d. J Drugs Dermatol. 2020 Jan 1;19(1):50-64. doi: 10.36849/JDD.2020.4508. J Drugs Dermatol. 2020. PMID: 31985912 Review.
19 results